Current Understanding of Neurofibromatosis Type 1, 2, and Schwannomatosis.
Tamura R.
Int J Mol Sci. 2021 May 29;22(11):5850. doi: 10.3390/ijms22115850.
The Diagnosis and Management of Neurofibromatosis Type 1.
Ly KI, Blakeley JO.
Med Clin North Am. 2019 Nov;103(6):1035-1054. doi: 10.1016/j.mcna.2019.07.004.
The Neurofibromatoses.
Farschtschi S, Mautner VF, McLean ACL, Schulz A, Friedrich RE, Rosahl SK.
Dtsch Arztebl Int. 2020 May 15;117(20):354-360. doi: 10.3238/arztebl.2020.0354.
Management of Central and Peripheral Nervous System Tumors in Patients with Neurofibromatosis.
Brown R.
Curr Oncol Rep. 2023 Dec;25(12):1409-1417. doi: 10.1007/s11912-023-01451-z. Epub 2023 Oct 31.
Neurofibromatosis.
Korf BR.
Handb Clin Neurol. 2013;111:333-40. doi: 10.1016/B978-0-444-52891-9.00039-7.
Living with neurofibromatosis.
Murphy L, Andrawis M, Beatty P, Costa Blasco M, Doyle C, McFeely O, O'Mahony S, Wolinska A, Connolly M.
Clin Exp Dermatol. 2023 Sep 19;48(10):1192-1193. doi: 10.1093/ced/llad228.
Neurofibromatosis.
Pearce JM.
J Neurol Neurosurg Psychiatry. 2003 Mar;74(3):384. doi: 10.1136/jnnp.74.3.384.
Neurofibromatosis.
WYLLIE WG.
Proc R Soc Med. 1947 Jul;40(9):546. doi: 10.1177/003591574704000940.
[Segmental neurofibromatosis].
Wagner G, Meyer V, Sachse MM.
Hautarzt. 2018 Jun;69(6):487-490. doi: 10.1007/s00105-017-4078-1.
Neurofibromatosis.
Goldberg NS.
Adv Dermatol. 1996;11:179-97; discussion 198.
